CPRX vs. TPL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or TPL.
Correlation
The correlation between CPRX and TPL is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CPRX vs. TPL - Performance Comparison
Loading data...
Key characteristics
CPRX:
1.04
TPL:
2.53
CPRX:
1.92
TPL:
2.91
CPRX:
1.22
TPL:
1.43
CPRX:
1.61
TPL:
3.70
CPRX:
6.30
TPL:
8.21
CPRX:
7.39%
TPL:
16.90%
CPRX:
41.30%
TPL:
55.92%
CPRX:
-94.25%
TPL:
-73.05%
CPRX:
-7.61%
TPL:
-17.91%
Fundamentals
CPRX:
$2.85B
TPL:
$32.31B
CPRX:
$1.57
TPL:
$20.39
CPRX:
14.90
TPL:
68.95
CPRX:
0.00
TPL:
0.00
CPRX:
5.34
TPL:
44.41
CPRX:
3.63
TPL:
26.79
CPRX:
$534.65M
TPL:
$727.66M
CPRX:
$441.72M
TPL:
$653.55M
CPRX:
$250.28M
TPL:
$586.43M
Returns By Period
In the year-to-date period, CPRX achieves a 13.94% return, which is significantly lower than TPL's 28.28% return. Over the past 10 years, CPRX has underperformed TPL with an annualized return of 21.49%, while TPL has yielded a comparatively higher 40.76% annualized return.
CPRX
13.94%
2.37%
9.64%
42.74%
39.35%
21.49%
TPL
28.28%
12.09%
4.33%
140.14%
54.58%
40.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. TPL — Risk-Adjusted Performance Rank
CPRX
TPL
CPRX vs. TPL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CPRX vs. TPL - Dividend Comparison
CPRX has not paid dividends to shareholders, while TPL's dividend yield for the trailing twelve months is around 1.10%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TPL Texas Pacific Land Corporation | 1.10% | 1.58% | 0.83% | 1.37% | 0.88% | 3.58% | 0.77% | 0.75% | 0.30% | 0.10% | 0.22% | 0.23% |
Drawdowns
CPRX vs. TPL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than TPL's maximum drawdown of -73.05%. Use the drawdown chart below to compare losses from any high point for CPRX and TPL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CPRX vs. TPL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) and Texas Pacific Land Corporation (TPL) have volatilities of 10.94% and 10.66%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CPRX vs. TPL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Texas Pacific Land Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPRX vs. TPL - Profitability Comparison
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.
TPL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported a gross profit of 172.92M and revenue of 195.98M. Therefore, the gross margin over that period was 88.2%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.
TPL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported an operating income of 150.07M and revenue of 195.98M, resulting in an operating margin of 76.6%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.
TPL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Texas Pacific Land Corporation reported a net income of 120.65M and revenue of 195.98M, resulting in a net margin of 61.6%.